Clinical Trials List
2020-03-01 - 2028-12-31
Phase III
Recruiting8
ICD-10C22.0
Liver cell carcinoma
ICD-10C22.2
Hepatoblastoma
ICD-10C22.3
Angiosarcoma of liver
ICD-10C22.4
Other sarcomas of liver
ICD-10C22.7
Other specified carcinomas of liver
ICD-10C22.8
Malignant neoplasm of liver, primary, unspecified as to type
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9155.0
Malignant neoplasm of liver, primary
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Ying-Chun Shen Division of Hematology & Oncology
- 楊宏志 Division of General Internal Medicine
- Ming-Chih Ho Division of General Surgery
- 林宗哲 Division of Hematology & Oncology
- Chien-Hung Chen Division of General Internal Medicine
- 洪俊銘 Division of General Internal Medicine
- TSUNG-HAO LIU Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- 吳志宏 Division of Radiology
- Ann-Lii Cheng Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
- 蘇東弘 Division of General Internal Medicine
- - - Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chiu Hung Chiu Digestive System Department
- Liu Yi-Sheng Division of Radiology
- 姜乃榕 Division of Hematology & Oncology
- 邱彥程 Digestive System Department
- Nai-Jung Chiang Division of Hematology & Oncology
- 吳毅晉 Digestive System Department
- Hsin-Yu Kuo Digestive System Department
- Yih-Jyh Lin Division of Others -
- 簡世杰 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 劉建廷 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- 鄭汝汾 Division of Radiology
- 吳佳哲 Division of Hematology & Oncology
- 歐信佑 Division of Radiology
- 李韋鋒 Division of General Surgery
- 陳彥豪 Division of Hematology & Oncology
- 賴香蘭 Division of Hematology & Oncology
- 劉約維 Division of General Surgery
- Yu-Li Su Division of Hematology & Oncology
- Shau-Hsuan Li Division of Hematology & Oncology
- 余俊彥 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 蔡炘儒 Digestive System Department
- Sheng-Shun Yang Digestive System Department
- 呂宜達 Digestive System Department
- 張碧倚 Division of Radiology
- 賴家鈺 Division of General Surgery
- CHUNG-HSIN CHANG Digestive System Department
- 劉嘯天 Division of General Surgery
- 鄭紹彬 Division of General Surgery
- 林宛姿 Digestive System Department
- 廖苡君 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Po-Heng Chuang Digestive System Department
- 楊宏仁 Division of General Surgery
- 陳德鴻 Division of General Surgery
- 陳永芳 Division of Radiology
- Hsueh-Chou Lai Digestive System Department
- 許士超 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Pei-Chang Lee Digestive System Department
- Yi-Ping Hung Division of Radiation Therapy
- 吳啟榮 Digestive System Department
- Chien-An Liu Division of Radiology
- 齊振達 Digestive System Department
- I-Cheng Lee Digestive System Department
- Rheun-Chuan Lee Division of Radiology
- San-Chi Chen Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shih-Chang Chuang Division of Gastroenterological Surgery
- Chia-Yen Dai Digestive System Department
- 吳嘉仁 Division of Radiology
- Chung-Feng Huang Digestive System Department
- Ming-Lung Yu Digestive System Department
- Jee-Fu Huang Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
450 participants
